Alexander & Baldwin Inc (Hawaii)
F:ABU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alexander & Baldwin Inc (Hawaii)
F:ABU
|
US |
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
|
U
|
UBE Corp
DUS:UBE
|
JP |
|
Kid ASA
F:97Q
|
NO |
|
M
|
Mckesson Corp
F:MCK
|
US |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABU's stock price target?
Not Available
ABU does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Alexander & Baldwin Inc (Hawaii)?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Alexander & Baldwin Inc (Hawaii)?
Projected CAGR
50%
Over the last 14 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 50%.
What is the Net Income forecast for Alexander & Baldwin Inc (Hawaii)?
Projected CAGR
-8%
Over the last 14 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 2 years is -8%.
